Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
Despite medical cannabis being legal in the UK for almost eight years, many patients remain hesitant or unsure about whether it is right for them. While awareness of the legality […]
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
The former heavyweight boxing contender revealed he is using prescribed medical cannabis to manage chronic pain.
Researchers say it could help identify those most at risk of developing psychosis.
A new policy model aims to integrate women’s health conditions into medical cannabis frameworks across Europe.
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
The guide aims to help patients travel safely, confidently, and within the law.
A survey of more than 3,500 patients in Germany found that more than half were able to reduce their use of other medications.
More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates, high-level networking, and the 2026 Business of Cannabis Awards.
People who consumed THC were more likely to recall words that were never shown to them.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
New research suggests that long-term, heavy cannabis use is associated with subtle changes to the brain’s frontal cortex.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
It is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university.
A new study suggests a combination approach may provide the benefits of THC treatment with fewer negative side effects.
A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped.
Lab studies find that a combination of THC and CBD kills ovarian cancer cells without harming healthy cells
Chancellor Rachel Reeve’s recent budget announcement is yet to be fully digested, and the implications for UK businesses and the wider public are still being analysed. However, one thing remains […]
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study. The study, published […]
The authors say the guidance aims to address “clear gaps” in prescriber training and education.
